Charles B. Simone, II, MD, FASTRO, FACRO is Research Professor and Chief Medical Officer of the New York Proton Center and Full Member in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center.  He is an internationally recognized expert in using proton therapy to treat thoracic malignancies and for reirradiation, and in developing clinical trials and innovative research in thoracic oncology and stereotactic body radiation therapy. 

Prior to coming to NYPC, Dr. Simone was Chief of the Thoracic Oncology Service at the Hospital of the University of Pennsylvania, Director of the Penn Mesothelioma and Pleural Program, and Director of Clinical Research and Operations in the Department of Radiation Oncology at Penn.  He was then appointed Medical Director of the Maryland Proton Treatment Center, and at University of Maryland, he also served as Chair of the Clinical Research Committee for their Comprehensive Cancer Center, proton therapy Fellowship Director, and Director of the Stereotactic Radiation Therapy Program.  He completed his undergraduate and medical school training at University of Pennsylvania and residency in radiation oncology at the National Cancer Institute (NCI), NIH, where he served as chief resident. 

Dr. Simone is a National Institutes of Health, National Science Foundation, and Department of Defense funded investigator who has published >560 scientific articles and chapters, given >500 scientific lectures to national/international audiences, and is the national Principal Investigator or Co-Chair of 8 NIH-funded cooperative group trials (5 NRG Oncology, 1 SWOG, 1 ECOG-ACRIN, 1 PCG).  He is a three-time Association of Residents in Radiation Oncology Educator of the Year Award winner.  Dr. Simone is the Proton Collaborative Group (PCG) Board President.  He Chairs the American Society for Radiation Oncology (ASTRO) Lung Resource Panel Committee, ASTRO Blue Ribbon Lung Panel, NRG Oncology Particle Therapy Work Group, PCG Lung Committee, American Radium Society (ARS) Appropriate Use Criteria Thoracic Committee, PCG Lung Committee, American College of Radiation Oncology (ACRO) Scientific Program Committee, NCI/Radiosurgery Society GRID-Lattice-Microbeam-Flash Radiotherapy Clinical Working Group, Varian FlashForward Consortium Clinical Committee, Varian Proton Connect Users Group, and multiple Particle Therapy Co-Operative Group (PTCOG) subcommittees.  He is Editor-in-Chief of Annals of Palliative Medicine and on the Editorial Boards of Frontiers in Oncology, Translational Lung Cancer Research, Cancers, Journal of Thoracic Disease, Annals of Translational Medicine, and Therapeutic Radiology and Oncology, among others.